Literature DB >> 16879496

Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.

L A Stevens1, D J Sellers, N G McKay, C R Chapple, R Chess-Williams.   

Abstract

1 Bladder smooth muscle sensitivity to muscarinic agonists is increased in the overactive bladder. Treatment of rats with streptozotocin induces a diabetic state in which the bladder muscle is overactive and also supersensitive to muscarinic agonists. This study has examined bladder contraction, muscarinic receptor density and receptor/G-protein coupling in the streptozotocin-induced overactive bladder of the rat. 2 Diabetes was induced by a single intraperitoneal dose of streptozotocin. Seven days later contraction of isolated detrusor muscle strips was assessed in tissue bath experiments, while receptor density was assayed in saturation experiments with [3H]-QNB (quinuclidinyl benzilate, L-[benzilic-4,4'-3H]) and receptor/G-protein coupling was determined in agonist displacement experiments with this radioligand. 3 Isolated detrusor strips from diabetic animals displayed an enhanced degree of spontaneous activity (0.060 +/- 0.016 g mg(-1), compared with 0.015 +/- 0.004 g mg(-1), P < 0.05). Carbachol produced contractile responses in tissues from both control and diabetic rats, but the diabetic tissues were more sensitive to this agonist, the pEC50 being 6.52 +/- 0.17 compared with 5.93 +/- 0.06 in controls (P < 0.001). Maximum responses to carbachol were similar in both groups of animals. The increase in carbachol potency was accompanied by a 40% increase in receptor density from 158 +/- 5 to 221 +/- 22 fmol mg(-1) protein (P < 0.05), but this was not enough to fully account for the change in tissue sensitivity. 4 In the absence of GTP-gamma-S, carbachol displaced [3H]-QNB from two binding sites, the high-affinity site (pKi = 7.06 +/- 0.26) which represents the receptors coupled to G-proteins made up 43.1 +/- 5.9% of the total binding sites in control tissues and this value was similar (41.0 +/- 4.0%) in the diabetic tissues (pKi = 6.64 +/- 0.31). In the presence of GTP-gamma-S, carbachol displaced [3H]-QNB from a single binding site which had a low-affinity, similar to the low-affinity site observed in the absence of GTP-gamma-S. 5 These data demonstrate that detrusor supersensitivity is observed after only 1 week of untreated diabetes in the rat. The overactivity is associated with an enhanced sensitivity to carbachol, which is partly explained by an increase in receptor density, but there appears to be no change in receptor/G-protein coupling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879496     DOI: 10.1111/j.1474-8673.2006.00371.x

Source DB:  PubMed          Journal:  Auton Autacoid Pharmacol        ISSN: 1474-8665


  11 in total

1.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

2.  Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder.

Authors:  K J Pak; R S Ostrom; M Matsui; F J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

Review 3.  Big-conductance Ca2+-activated K+ channels in physiological and pathophysiological urinary bladder smooth muscle cells.

Authors:  Shankar P Parajuli; Yun-Min Zheng; Robert Levin; Yong-Xiao Wang
Journal:  Channels (Austin)       Date:  2016-04-21       Impact factor: 2.581

4.  Normalization of organ bath contraction data for tissue specimen size: does one approach fit all?

Authors:  Betul R Erdogan; Irem Karaomerlioglu; Zeynep E Yesilyurt; Nihal Ozturk; A Elif Muderrisoglu; Martin C Michel; Ebru Arioglu-Inan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-11       Impact factor: 3.000

5.  Using gene chips to identify organ-specific, smooth muscle responses to experimental diabetes: potential applications to urological diseases.

Authors:  Jason D Hipp; Kelvin P Davies; Moses Tar; Mira Valcic; Abraham Knoll; Arnold Melman; George J Christ
Journal:  BJU Int       Date:  2007-02       Impact factor: 5.588

6.  Type 2 diabetes mellitus and risk of stress, urge and mixed urinary incontinence.

Authors:  Kim N Danforth; Mary K Townsend; Gary C Curhan; Neil M Resnick; Francine Grodstein
Journal:  J Urol       Date:  2008-11-14       Impact factor: 7.450

7.  Diabetic plasticity of non-adrenergic non-cholinergic and P2X-mediated rat bladder contractions.

Authors:  Alvaro Munoz; Timothy B Boone; Christopher P Smith; George T Somogyi
Journal:  Brain Res Bull       Date:  2013-04-02       Impact factor: 4.077

8.  Changes of phasic and tonic smooth muscle function of jejunum in type 2 diabetic Goto-Kakizaki rats.

Authors:  Jing-Bo Zhao; Peng-Min Chen; Hans Gregersen
Journal:  World J Diabetes       Date:  2013-12-15

9.  Combination drug therapy against OAB normalizes micturition parameters and increases the release of nitric oxide during chemically induced cystitis.

Authors:  Bhavik Patel; Fernando Perez; Patrik Aronsson; Ranya Alothmani; Thomas Carlsson; Michael Winder
Journal:  Pharmacol Res Perspect       Date:  2020-02

10.  Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study.

Authors:  Hoon Choi; Jae Hyun Bae; Cheol Young Oh; Seong Jin Jeong; Woo Jin Ko; Jong Bo Choi; Ju Tae Seo; Dong Hwan Lee; Joon Chul Kim; Kwang Woo Lee; Young Ho Kim
Journal:  Int Neurourol J       Date:  2018-03-31       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.